Sale!

SCN1A Gene Early infantile epileptic encephalopathy type 6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SCN1A gene is critical in the proper functioning of brain cells, and mutations in this gene can lead to a range of epileptic disorders, including Early Infantile Epileptic Encephalopathy Type 6 (EIEE6). EIEE6 is a severe form of epilepsy that emerges in the first few months of life, characterized by frequent seizures and significant developmental delays. Genetic testing for mutations in the SCN1A gene is essential for diagnosing EIEE6, guiding treatment options, and providing information on the condition’s prognosis.

DNA Labs UAE offers a specialized genetic test to identify mutations in the SCN1A gene associated with Early Infantile Epileptic Encephalopathy Type 6. This test is a vital tool for families seeking answers about this challenging condition. The cost of the SCN1A gene test at DNA Labs UAE is 4400 AED. By conducting this test, healthcare professionals can confirm the diagnosis of EIEE6, enabling them to tailor a treatment plan that can potentially improve the quality of life for affected infants and provide families with crucial information regarding the condition’s management and outlook.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN1A Gene Early Infantile Epileptic Encephalopathy Type 6 Genetic Test

Test Name: SCN1A Gene Early Infantile Epileptic Encephalopathy Type 6 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SCN1A Gene Early Infantile Epileptic Encephalopathy Type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN1A Gene Early Infantile Epileptic Encephalopathy Type 6.

Test Details: The SCN1A gene is associated with Early Infantile Epileptic Encephalopathy Type 6 (EIEE6), a rare genetic disorder characterized by seizures that begin in the first months of life. The disorder is caused by mutations in the SCN1A gene, which provides instructions for making a protein called Nav1.1 that helps regulate the flow of sodium ions into cells in the brain.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously, allowing for a more comprehensive evaluation of genetic mutations. In the case of EIEE6, NGS testing can identify mutations in the SCN1A gene that may be causing the disorder. NGS genetic testing for EIEE6 may involve sequencing the entire SCN1A gene or specific regions of the gene known to be associated with the disorder.

The results of the test can help confirm a diagnosis of EIEE6 and guide treatment decisions. Additionally, genetic testing can provide valuable information for family members who may be at risk of inheriting the disorder.

Test Name SCN1A Gene Early infantile epileptic encephalopathy type 6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN1A Gene Early infantile epileptic encephalopathy type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN1A Gene Early infantile epileptic encephalopathy type 6
Test Details

The SCN1A gene is associated with Early Infantile Epileptic Encephalopathy Type 6 (EIEE6), a rare genetic disorder characterized by seizures that begin in the first months of life. The disorder is caused by mutations in the SCN1A gene, which provides instructions for making a protein called Nav1.1 that helps regulate the flow of sodium ions into cells in the brain.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously, allowing for a more comprehensive evaluation of genetic mutations. In the case of EIEE6, NGS testing can identify mutations in the SCN1A gene that may be causing the disorder.

NGS genetic testing for EIEE6 may involve sequencing the entire SCN1A gene or specific regions of the gene known to be associated with the disorder. The results of the test can help confirm a diagnosis of EIEE6 and guide treatment decisions. Additionally, genetic testing can provide valuable information for family members who may be at risk of inheriting the disorder.